US Patent Litigations are now available. Check here

Explore Jiangsu Hengrui Medicine's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3093295May 27, 2020Il-15 Heterogeneous Dimer Protein And Uses Thereof2